Vectors for gene therapy of cardiovascular disease
✍ Scribed by Jean-François Dedieu; Abderrahim Mahfoudi; Aude Le Roux; Didier Branellec
- Book ID
- 107534654
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 495 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1523-3782
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In a review article Miller [1] reported on the state of the art of human gene therapy as it was summarized in a meeting at the end of December 1991. The human trials in which human genes were successfully transferred in vitro to mark cells of patients and for gene therapy of genetic disorders. The a
but very interesting that the negative regulation of the cell cycle that protects from HCC development relies exclusively on p21. The promising idea behind the inactivation of p21 in Fah Ϫ/Ϫ mice was to reactivate apoptosis in order to first eliminate DNA-damaged hepatocytes followed by balanced li